Grocery Outlet, a California-based extreme value grocery chain bought out by Hellman & Friedman last fall, is looking to reprice a $450 million term loan B it allocated in October to fund the takeover.
Spectrum plans to fund the purchase through a combination of new debt backed by Credit Suisse, Deutsche Bank and Jefferies, along with $500 million in Spectrum Brands common stock.
Aspen Dental Management closed on an upsized $435 million loan offering Monday following a price flex that narrowed terms on the facility funding a major investment by middle-market private equity firm American Securities.
Sterigenics-Nordion has launched a $1.2 billion loans offering to leverage the major-stake investment that one of its sponsors Warburg Pincus announced last month.
A joint venture formed by Australian construction giant Leighton Holdings Ltd. and Apollo Global Management has launched a multi-currency, $900 million-equivalent loans proposal to finance its formation and provide start-up collateral.
Digital data collection company Research Now Group priced and allocated a package of first- and second-lien loans Wednesday, raising funds to close on its buyout by private equity firm Court Square Partners, according to KDP Investment Advisors.
Valeant Pharmaceuticals on Friday wrapped $14.15 billion in debt funding for its plans to acquire Salix Pharmaceuticals, despite a rival unsolicited bid by Endo International for Salix that surfaced this week.
Endo International confirmed Wednesday it has submitted an unsolicited $15.7 billion takeover bid for Salix Pharmaceuticals. But Valeant Pharmaceuticals said it planned to stay the course with its $14.5 acquisition agreement with Salix, and is moving forward with bond and loan offerings that hit the market this week to finance the merger.
Walgreens Infusion Services, a planned spinoff of the drugstore chains specialty intravenous therapy unit, is launching a $415 million term loan B proposal to fund Madison Dearborn Partners majority stake purchase in the new company.
The loans are part of a $15.15 billion debt commitment Valeant Pharmaceuticals has received for its $14.5 billion proposed takeover of Salix Pharmaceuticals. Valeant also revealed it will also seek $9.6 billion through an unsecured private-sale notes offering.
Firm: Eagle Point Credit Management